JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 28 No. 9 1401-1407
© 1987 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gross, M. D.
Right arrow Articles by Brady, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gross, M. D.
Right arrow Articles by Brady, T.

Functional and Scintigraphic Evaluation of the Silent Adrenal Mass

Milton D. Gross, Gary P. Wilton, Brahm Shapiro, Kyung Cho, Barry I. Samuels, J. Antonio Bouffard, Gary Glazer, Roger J. Grekin and Terry Brady

Department of Internal Medicine, Divisions of Nuclear Medicine and Endocrinology & Metabolism and Department of Radiology, The Veterans Administration and The University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence: For reprints contact: M.D. Gross, MD (115), Nuclear Medicine Service, Veteran's Administration Medical Center, 2215 Fuller Rd., Ann Arbor, MI 48105.

ABSTRACT

Seven patients with unilateral and one patient with bilateral and asymmetric (R > L) incidentally discovered adrenal mass abnormalities depicted by computed tomography (CT) were studied by 131I-6ß-iodomethyl-19-norcholesterol (NP-59) scintigraphy. There was marked lateralization of NP-59 uptake to the side of the mass lesion in the seven patients with unilateral masses and prominent asymmetric, (R > L) bilateral uptake in the patient with bilateral masses despite the fact that there were no obvious abnormalities of adrenocortical or adrenomedullary function as determined from peripheral blood and 24-hr urinary hormone measurements. Simultaneous bilateral adrenal vein catheterization (AVC) was employed to measure the levels of hormone effluent from the adrenal cortex and medulla and in all instances the cortisol concentrations were greatest from the side of the mass lesion in those patients with unilateral masses and from the larger of the two adrenals in the patient with bilateral adrenal masses. Thus, there was congruence between the anatomic (CT) and functional (NP-59 scintigraphy and AVC) investigations that depicted asymmetry of the adrenal glands which were not associated with abnormalities of overall adrenal function or hypothalamic-pituitary-adrenal axis integrity.

FOOTNOTES

Presented in part to the American Federation for Clinical Research, May 2–4, 1985, Washington DC.




This article has been cited by other articles:


Home page
JNMHome page
G. La Cava, A. Imperiale, C. Olianti, G. R. Gheri, C. Ladu, M. Mannelli, and A. Pupi
SPECT Semiquantitative Analysis of Adrenocortical 131I-6{beta}-Iodomethyl-Norcholesterol Uptake to Discriminate Subclinical and Preclinical Functioning Adrenal Incidentaloma
J. Nucl. Med., July 1, 2003; 44(7): 1057 - 1064.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri’, and M. Boscaro
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates
J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 55 - 62.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1987 by the Society of Nuclear Medicine.